Hypertension

Intensive Blood Pressure Control May Cut Mortality in CKD

Publish Date April 18, 2019

Targeting a systolic blood pressure below 130 mm Hg was associated with a 21% decreased risk of all-cause mortality among patients with stage 3 to 4 chronic kidney disease, a meta-analysis found.

Intensive BP Lowering May Up Cognitive Decline in Elderly

Publish Date April 16, 2019

For those on antihypertensive treatment, cognitive decline greater with SBP <130 versus >150 mm Hg

Normalizing BP in Elderly With Hypertension May Up Mortality

Publish Date April 15, 2019

Blood pressure values less than 140/90 mm Hg tied to increased mortality risk for octogenarians

Here’s a List of Nitrosamine-Free ARB Medications, According to the FDA

Publish Date April 9, 2019

As part of the ongoing safety investigation of potentially carcinogenic impurities detected in angiotensin II receptor blocker (ARB) medications.

Statins Plus Intensive SBP Control May Up Survival in Nondiabetic CKD

Publish Date April 3, 2019

For nondiabetic CKD patients taking statins, targeting an intensive SBP goal of less than 120 mm significantly reduced the risks for all-cause and cardiovascular mortality by 56% and 71%, respectively, study finds.

Lifetime Hypertension Risk High for Black Men and Women, White Men

Publish Date March 28, 2019

Lifetime risks are higher under AHA/ACC 2017 HTN threshold than JNC7 threshold for hypertension

Ultrasound Surgery May Help Control Blood Pressure

Publish Date March 26, 2019

At six months, patients who underwent renal denervation used less medication to control BP

AHA: Nearly Half of US Adults Have Cardiovascular Disease

Publish Date February 5, 2019

Forty-six percent of US adults have hypertension

Intensive Blood Pressure Tx Does Not Reduce Dementia Risk

Publish Date January 30, 2019

But drop seen in risk for MCI and combined rate of cognitive impairment, probable dementia

BP >120/80 mm Hg Linked to Lower Gray Matter Volume

Publish Date January 25, 2019

Lower regional gray matter volume tied to higher peripheral BP in young adults aged 19 to 40 years